DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹107 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr | ₹177 Cr |
What is the latest Contingent Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹107 Cr |
Mar2023 | ₹107 Cr |
Mar2022 | ₹108 Cr |
Mar2021 | ₹96 Cr |
Mar2020 | ₹177 Cr |
How is Contingent Liabilities of DR REDDYS LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹107 Cr | 0.00 | |
Mar2023 | ₹107 Cr | -0.37 | |
Mar2022 | ₹108 Cr | 11.62 | |
Mar2021 | ₹96 Cr | -45.48 | |
Mar2020 | ₹177 Cr | - |
Compare Contingent Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹113,754.9 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,512.2 Cr | 1.4% | -6.4% | 11.8% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 3.2% |
11.8% |
11.4% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses